-

Global Cellular Health Testing Industry (2020 to 2027) - Growing Popularity of Direct-To-Consumer Approach to Testing Drives Market Demand - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Cellular Health Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Cellular Health Testing estimated at US$2.4 Billion in the year 2020, is projected to reach a revised size of US$4.2 Billion by 2027, growing at a CAGR of 8.5% over the period 2020-2027.

Single-Test Panels, one of the segments analyzed in the report, is projected to record 7.4% CAGR and reach US$2.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Multi-Test Panels segment is readjusted to a revised 10.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $695.6 Million, While China is Forecast to Grow at 8% CAGR

The Cellular Health Testing market in the U.S. is estimated at US$695.6 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$729.1 Million by the year 2027 trailing a CAGR of 8.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8% and 7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7% CAGR.

Select Competitors (Total 46 Featured):

  • Bio-Reference Laboratories, Inc.
  • Cell Science Systems Corp.
  • Cleveland Heartlab, Inc.
  • Dna Labs India
  • Genova Diagnostics
  • Immundiagnostik AG
  • Laboratory Corporation of America Holdings
  • Life Length
  • Quest Diagnostics, Inc.
  • Repeat Diagnostics Inc. (Repeat Dx)
  • Segterra, Inc.
  • SpectraCell Laboratories, Inc.
  • Telomere Diagnostics, Inc. (Tdx)
  • Zimetry LLC

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Cellular Health Testing - Revolutionary Technology Provides Overview of Health at Cellular Level
  • North America Projected to Retain Maximum Share in the Market
  • Rising Demand for Accurate Telomere Length Test Steers Market Growth
  • Digital Transformation in Healthcare to Offer Significant Market Gains
  • Focus on Healthy Life Expectancy (HLE) as a Measure of Population Health Promise Growth Opportunities
  • Cellular Approach to Tackle Chronic Diseases Ensure Steady Growth Prospects
  • Continuous Rise in Geriatric Population Throws Focus on Cellular Heath Screening
  • Government Policies and Measures Promoting Preventative Healthcare Augurs Well
  • Personalized and Precision Medicine Presents Application Opportunities for Cellular Health Screening
  • Growing Popularity of Direct-To-Consumer Approach to Testing Drives Market Demand
  • Key Challenges
  • Limited Reimbursement
  • Challenges in Sample Transportation
  • Variation in Pricing of Test Kits
  • Covid-19 Impact on Cellular Health Testing Market

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/uoxayy

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Sysmex Corp (6869) Product Pipeline Analysis Report 2025: Haematology, Haemostasis, and Urinalysis Analyzers - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Sysmex Corp (6869) - Product Pipeline Analysis, 2025 Update" company profile has been added to ResearchAndMarkets.com's offering. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. Sysmex Corp (Sysmex) is a provider of medical devices that researches, develops, manufactures and sells instruments, reagents, and s...

Ypsomed Holding AG (YPSN) Product Pipeline Analysis Report 2025: Self-Injection and Infusion Systems Portfolio - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Ypsomed Holding AG (YPSN) - Product Pipeline Analysis, 2025 Update" company profile has been added to ResearchAndMarkets.com's offering. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. Ypsomed Holding AG (Ypsomed) is a medical device company. It designs, develops, and manufactures injection and infusion syste...

Cochlear Ltd (COH) Product Pipeline Analysis Report 2025: Portfolio Includes Cochlear Implants, Bone Conduction Systems, Acoustic Implants, and Wireless Accessories - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Cochlear Ltd (COH) - Product Pipeline Analysis, 2025 Update" company profile has been added to ResearchAndMarkets.com's offering. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. Cochlear Ltd (Cochlear) is a medical device company that offers implantable hearing solutions to customers. It develops, manufacture...
Back to Newsroom